Nair Vinay’s Myriad Genetics MYGN Stock Holding History

Nair Vinay’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,271	Closed	-$222K	–	281
2015 Q1	$222K	Buy	+6,271	New	+$224K	0.15%	285

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nair Vinay's MYGN Position: Q2 2015 in Review

Nair Vinay sold out of Myriad Genetics (MYGN) in Q2 2015, closing a stake of 6,271 shares — an estimated $222K sold.

Nair Vinay first reported a position in MYGN in Q1 2015 and held it in 1 quarter. The position peaked at $222K in Q1 2015. 235 funds tracked by Wall St. Rank hold MYGN as of Q2 2015.

Nair Vinay reported no remaining Myriad Genetics position as of Q2 2015 after selling out during the quarter.
Nair Vinay sold 6,271 Myriad Genetics shares in Q2 2015, an estimated $222K.
Nair Vinay first reported a position in Myriad Genetics in Q1 2015 and held it in 1 quarter.
Nair Vinay's Myriad Genetics position peaked at $222K in Q1 2015.
235 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2015.

Based on Nair Vinay's 13F filing for Q2 2015, filed 12 Aug 2015.